Unknown

Dataset Information

0

Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.

ABSTRACT: Adequate lymph node evaluation is recommended for optimal staging in patients with malignant neoplasms including breast cancer. However, the role of negative lymph nodes (LNs) remains unclear in breast cancer according to N substage (N1, N2, and N3). In this study, for the first time, we analyzed the prognostic significance of negative LNs in breast cancer patients. A critical relationship was observed between negative LN count and survival, independent of patient characteristics and other related molecular variables including estrogen receptor (PR) status, progesterone receptor (ER) status, human epidermal growth factor receptor 2 (HER2) status, depth of tumor invasion and degree of differentiation. This research is of great importance in providing more information about the prognosis of breast cancer by statistical analysis of negative lymph nodes and can serve as a useful supplement to the current pathological system.

SUBMITTER: Zhao X 

PROVIDER: S-EPMC5858777 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.

Zhao Xin X   Wei Jing J   Li Xiaoxin X   Yang Haochang H   Wang Pei P   Cao Susheng S  

PloS one 20180319 3

Adequate lymph node evaluation is recommended for optimal staging in patients with malignant neoplasms including breast cancer. However, the role of negative lymph nodes (LNs) remains unclear in breast cancer according to N substage (N1, N2, and N3). In this study, for the first time, we analyzed the prognostic significance of negative LNs in breast cancer patients. A critical relationship was observed between negative LN count and survival, independent of patient characteristics and other relat  ...[more]

Similar Datasets

Unknown A nomogram improves AJCC stages for colorectal cancers by introducing CEA, modified lymph node ratio and negative lymph node count.
| S-EPMC5150581 | biostudies-literature
Unknown Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer.
| S-EPMC3096730 | biostudies-literature
Unknown Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.
| S-EPMC7041783 | biostudies-literature
Unknown The prognostic value of negative lymph node count for patients with gastric cancer who received preoperative radiotherapy.
| S-EPMC5564535 | biostudies-other
Unknown Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas.
| S-EPMC5193343 | biostudies-literature
Unknown Effect of lymph nodes count in node-positive gastric cancer.
| S-EPMC6843880 | biostudies-literature
Unknown BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
| S-EPMC6248959 | biostudies-literature
Unknown Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy.
| S-EPMC5642631 | biostudies-literature
Unknown DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients.
| S-EPMC5037364 | biostudies-literature
Unknown Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.
| S-EPMC2878181 | biostudies-literature